6d796be7-dac9-4cd6-a4f4-d3cd01320c8d.pdf

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.





UNIVERSAL HEALTH INTERNATIONAL GROUP HOLDING LIMITED

大健康國際集團控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 2211)


VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE MOVEMENT


We have noted the unusual movement in price of the shares of Universal Health International Group Holding Limited (the "Company") today, and is currently identifying the specific reasons. We have actively attempted to communicate with investors. As for the rumor in the public that, the unusual movement in the price of shares of the Company is in relation to Hang Fat Ginseng Holdings Company Limited ("Hang Fat Ginseng", stock code: 911) and Alibaba Health Information Technology Limited ("Ali Health", stock code: 0241). However, the board (the "Board") of directors of the Company wishes to clarify that, the agreement entered into between the Company and Hang Fat Ginseng last year was just a framework cooperation agreement and there is no cooperation in real sense between the parties so far. There is no further progress on the electronic cooperation of medical health agreed by the Company and Ali Health due to policy reasons. The shares of Mr. Jin Dongtao, the chairman of the Company, in the Company was increased by 4.36 million yesterday (being 28 January) at an average price of HK$2.3733 per share, totaling HK$10.35 million, and Mr. Jin Dongtao has full confidence in the future development of the Company. The current businesses of the Company in all respects are under normal operation.


Having made such enquiry with respect to the Company as is reasonable in the circumstances, the Board of the Company confirms that, as of the date of this announcement, it is not aware of any reasons for such price movement or of any information which have to be announced to avoid a false market in the Company's securities or of any inside information that needs to be disclosed under Part XIVA of the Securities and Futures Ordinance.

This is a voluntary announcement made by the Company.


By order of the Board

Universal Health International Group Holding Limited Chu Chuanfu

Executive Director


Hong Kong, 29 January 2016


As at the date of this announcement, the board of directors of the Company comprises four executive directors, namely, Mr. Jin Dongtao, Mr. Jin Dongkun, Mr. Chu Chuanfu and Mr. Zhao Zehua and three independent non-executive directors, namely, Mr. Cheng Sheung Hing, Ms. Chiang Su Hui Susie and Ms. Hao Jia.

Jintian Pharmaceutical Group Ltd. issued this content on 29 January 2016 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 29 January 2016 14:32:14 UTC

Original Document: http://www.jtyyjt.com/d/file/touzizheguanxi/gonggaojigonghan/2016/2016-01-29/7167a08cbef1560f2b62b5a2b80be4e4.pdf